AI is about to change healthcare. These 38 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Sally Beauty, you need to believe its focus on exclusive, professional-grade brands can offset pressures from price-sensitive shoppers and slower traffic. The EBIN New York expansion supports that story by deepening a differentiated category, but it does not change the near term focus on stabilizing care category sales or the key risk around soft demand and value-driven trade down.
Among recent announcements, the August 2026 guidance update stands out: management slightly trimmed full year net sales expectations to US$3.725–3.733 billion. Against that backdrop, the EBIN New York rollout at select stores and online may modestly support Sally Beauty’s at home salon shopper appeal, but investors are still watching how updated guidance, margins, and category mix evolve in upcoming quarters.
Yet investors also need to weigh how persistent consumer frugality and increased price sensitivity could affect Sally Beauty’s ability to sustain its premium mix and pricing power...
Read the full narrative on Sally Beauty Holdings (it's free!)
Sally Beauty Holdings' narrative projects $3.9 billion revenue and $260.8 million earnings by 2029. This requires 1.7% yearly revenue growth and an earnings increase of about $76.9 million from $183.9 million.
Uncover how Sally Beauty Holdings' forecasts yield a $16.40 fair value, in line with its current price.
Some of the most optimistic analysts were assuming Sally Beauty could lift earnings to about US$260.7 million by 2029 and improve margins, so if you believe EBIN’s expanded assortment supports that kind of at home growth story, you may see more upside than consensus, while others will focus on the risk that slow digital execution could still limit the payoff from deals like this.
Explore 3 other fair value estimates on Sally Beauty Holdings - why the stock might be worth over 4x more than the current price!
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com